cisapride has been researched along with Cancer of Stomach in 6 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dyspepsia affects one in four Australians; of those who present in general practice, the majority will have functional or non-ulcer dyspepsia, with no structural explanation for their symptoms." | 2.39 | Modern management of dyspepsia. ( Talley, NJ, 1996) |
| "The proliferation of gastric cancer cells expressing HERG protein was inhibited in a time- and dose-dependent manner when treated with cisapride (P<0." | 1.33 | The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells. ( Fan, DM; Hao, ZM; Hong, L; Shao, XD; Wu, KC; Zhang, J, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shao, XD | 1 |
| Wu, KC | 1 |
| Hao, ZM | 1 |
| Hong, L | 1 |
| Zhang, J | 1 |
| Fan, DM | 1 |
| Talley, NJ | 1 |
| Tomita, R | 3 |
| Tanjoh, K | 3 |
| Munakata, K | 1 |
| Takizawa, H | 1 |
| Shibata, Y | 1 |
| Nimura, Y | 1 |
| Toyoda, S | 1 |
| Yasui, A | 1 |
| Kawamura, T | 1 |
| Fujisaki, S | 1 |
| Fukuzawa, M | 1 |
1 review available for cisapride and Cancer of Stomach
| Article | Year |
|---|---|
Modern management of dyspepsia.
Topics: Adult; Aged; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Child; C | 1996 |
1 trial available for cisapride and Cancer of Stomach
| Article | Year |
|---|---|
Physiologic effects of cisapride on gastric emptying after pylorus-preserving gastrectomy for early gastric cancer.
Topics: Adult; Aged; Cisapride; Female; Gastrectomy; Gastric Emptying; Gastrointestinal Agents; Humans; Male | 1998 |
4 other studies available for cisapride and Cancer of Stomach
| Article | Year |
|---|---|
The potent inhibitory effects of cisapride, a specific blocker for human ether-a-go-go-related gene (HERG) channel, on gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cisapride; ERG1 Potassium Channel; Ether-A-Go-Go Potas | 2005 |
The role of motilin and cisapride in the enteric nervous system of the lower esophageal sphincter in humans.
Topics: Aged; Cholinergic Fibers; Cisapride; Esophageal Neoplasms; Esophagogastric Junction; Female; Gastroi | 1997 |
Acid reflux test for gastroesophageal reflux after distal gastrectomy: diagnosis and clinical effect of cisapride.
Topics: Adult; Aged; Anti-Ulcer Agents; Barium Sulfate; Chest Pain; Cisapride; Contrast Media; Esophagitis, | 1998 |
Relation between gastroduodenal interdigestive migrating motor complex and postoperative gastrointestinal symptoms before and after cisapride therapy following distal gastrectomy for early gastric cancer.
Topics: Adult; Aged; Cisapride; Duodenum; Female; Gastrectomy; Gastrointestinal Agents; Humans; Male; Middle | 2000 |